<DOC>
	<DOCNO>NCT01686269</DOCNO>
	<brief_summary>Vascular stenosis result neointimal hyperplasia major clinical problem impact multiple diverse discipline , include cardiology ( coronary restenosis ) , cardiothoracic vascular surgery ( saphenous vein polytetrafluoroethylene [ PTFE ] graft failure ) , neurology ( carotid stenosis ) , nephrology ( dialysis access dysfunction ) , transplant medicine ( chronic allograft rejection heart kidney ) . [ 1 ] In marked contrast deleterious effect smooth muscle progenitor cell neointimal hyperplasia , circulate endothelial progenitor cell ( EPCs ) believe play important role vascular repair inhibition neointimal hyperplasia . [ 2 ] Endothelial progenitor cell ( EPCs ) circulate adult peripheral blood contribute neovascularization . Satoshi et al . demonstrate lineage-committed EPCs CD34-positive mononuclear cell , putative precursor , mobilize acute ischemic event human . [ 3 ] Reduced level circulate EPCs independently predict atherosclerotic disease progression , thus support important role endogenous vascular repair modulate clinical course coronary artery disease . [ 4 ] These observation prompt hypothesis circulate EPCs may provide endogenous repair mechanism counteract surgery-induced endothelial cell injury replace dysfunctional endothelium perioperatively . Therefore , investigator examine whether level circulate EPCs correlate time course outcomes coronary artery bypass surgery establish clinical role endogenous endothelial repair mediate circulate EPCs .</brief_summary>
	<brief_title>Endothelial Progenitor Cells</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>age 18 85 year sign write informed consent angiographically document coronary artery disease indicate coronary artery bypass surgery clinical biochemical evidence presence concomitant inflammatory disease chronic renal insufficiency ( serum creatinine &gt; 1.4 mmol/L ) impair left ventricular ejection fraction ( &lt; 45 % ) autoimmune malignant disease thrombocytopenia ( &lt; 100 000/L ) anemia ( hemoglobin &lt; 8.5 g/dL ) inability understand consent form previous coronary bypass surgery severe peripheral arterial occlusive disease atrial fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Endothelial progenitor cell</keyword>
	<keyword>coronary artery bypass</keyword>
</DOC>